a year ago

CellVoyant Raises £7.6M in Seed Funding for Stem Cell Therapies

  • CellVoyant, a UK-based AI-first biotechnology spin-out, raised £7.6M in Seed funding, led by Octopus Ventures, to scale the business, expand infrastructure, and advance AI capabilities.

      • ProblemHealthcare

      "The problem CellVoyant is trying to solve is accelerating the development of new stem cell therapies."

      Solution

      "CellVoyant is creating novel stem cell-based therapies for chronic diseases using AI-first live cell imaging to predict and optimise stem cell differentiation, to controllably manufacture any cell and tissue in the body at scale."

      Covered on